Note 11 - Goodwill and Intangibles (Details Textual) |
6 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Mar. 31, 2024
USD ($)
|
Mar. 31, 2023
USD ($)
|
Sep. 30, 2023
USD ($)
|
|
| Goodwill, Impairment Loss | $ 0 | ||
| Number of Patents Granted | 51 | ||
| Impairment of Intangible Assets (Excluding Goodwill), Total | $ 0 | ||
| Amortization of Intangible Assets | $ 663,000 | $ 555,000 | |
| Patents [Member] | |||
| Finite-Lived Intangible Asset, Useful Life | 20 years | ||
| X | ||||||||||
- Definition Represents the number of patents granted in the United States. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|